Jerusalem Pharmaceutical Co (XPAE:JPH) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAE:JPH Jerusalem Pharmaceutical Co XPAE:JPH
82 GF Score
Price $3.57
GF Value $2.41
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Jerusalem Pharmaceutical Co FFO?

FFO (Funds from operations) only applies to REITs.

XPAE:JPH
82GF Score
Jerusalem Pharmaceutical Co XPAE:JPH
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jerusalem Pharmaceutical Co (XPAE:JPH) Overvalued in 2026?

Based on GuruFocus' analysis, Jerusalem Pharmaceutical Co stock appears to be overvalued. The current stock price of $3.57 is trading 48.1% above its estimated GF Value™ of $2.41. GuruFocus considers Jerusalem Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for XPAE:JPH:

  • FFO:
  • GF Value™: $2.41 vs. price of $3.57 (48.1% above fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the XPAE:JPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jerusalem Pharmaceutical Co Business Description

Address Nablus Street, Jerusalem Pharmaceuticals Company Buliding, Al Bireh Industrial Zone, Al Bireh, PSE, 3570
Jerusalem Pharmaceutical Co is engaged in developing, manufacturing and marketing of human pharmaceuticals products. It also produces detergent, cosmetic, personal and home care products, veterinary and agricultural products. The company operates in Jordan, Algeria, the Middle East, and North Africa Region. Its product portfolio contains more than 300 pharmaceutical products in various dosage forms including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, ointments, as well as ear and nose drops and solutions.
82GF Score

Get the complete analysis for XPAE:JPH

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.57
Price
$2.41
GF Value